#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17408	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2222	777.6	0	.	n	.	0	C1450T	SNP	1450	1450	C	1662	1662	T	929	T,C	872,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	17408	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2222	777.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1396	1396	C	1017	C	950	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32520	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3550	913.1	0	.	n	.	0	T695C	SNP	695	695	T	1005	1005	C	987	C,T	924,4	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32520	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3550	913.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2281	2281	C	985	C,T	925,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32520	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3550	913.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2355	2355	A	1036	A	981	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	32520	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3550	913.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2907	2907	C	1010	C	966	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2496	folP	855	855	100.0	folP.l15.c4.ctg.1	1600	155.5	1	SNP	p	R229S	1	.	.	685	687	AGC	1059	1061	AGC	266;267;266	A;G;C	254;257;254	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6494	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3413	189.6	1	SNP	p	S91F	1	.	.	271	273	TTC	594	596	TTC	227;225;224	T;T;C	213;213;213	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6494	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3413	189.6	1	SNP	p	G95N	0	.	.	283	285	GGC	606	608	GGC	222;221;221	G;G;C	209;206;211	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	6494	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3413	189.6	1	SNP	p	D95G	1	.	.	283	285	GGC	606	608	GGC	222;221;221	G;G;C	209;206;211	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_Y_01506	mtrR.WHO_Y_01506	1	1	27	2122	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1335	158.5	1	SNP	p	G45D	0	.	.	133	135	GGC	495	497	GGC	262;267;270	G;G;C	243;244;249	mtrR.WHO_Y_01506:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1024	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c17.ctg.1	942	107.5	0	.	n	.	0	A197.	DEL	197	197	A	550	550	A	235	A	221	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5638	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2874	195.1	1	SNP	p	D86N	0	.	.	256	258	GAC	556	558	GAC	221;219;220	G,A;A;C	209,1;204;208	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5638	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2874	195.1	1	SNP	p	S87I	0	.	.	259	261	AGT	559	561	AGT	222;224;225	A;G,T;T	210;214,1;212	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5638	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2874	195.1	1	SNP	p	S87R	0	.	.	259	261	AGT	559	561	AGT	222;224;225	A;G,T;T	210;214,1;212	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5638	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2874	195.1	1	SNP	p	S87W	0	.	.	259	261	AGT	559	561	AGT	222;224;225	A;G,T;T	210;214,1;212	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5638	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2874	195.1	1	SNP	p	S88P	0	.	.	262	264	TCC	562	564	TCC	225;228;226	T;C;C	209;215;211	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5212	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2676	194.0	0	.	p	.	0	P456S	NONSYN	1366	1368	CCC	1711	1713	TCC	235;230;233	T,C;C;C	211,2;217;218	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	5212	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2676	194.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1573	1575	GGC	243;240;241	G;G;C	230;228;227	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	A311V	0	.	.	931	933	GCA	1243	1245	GCA	291;292;290	G;C;A	265;269;271	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	I312M	0	.	.	934	936	ATC	1246	1248	ATC	291;292;289	A;T;C	273;275;273	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	V316T	0	.	.	946	948	GTG	1258	1260	GTG	279;283;285	G;T;G	264;267;269	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	V316P	0	.	.	946	948	GTG	1258	1260	GTG	279;283;285	G;T;G	264;267;269	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1762	1764	ACC	253;254;252	A;C;C,T	232;236;235,1	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1816	1818	GCG	236;235;235	G;C;G,A	209;185;196,1	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1816	1818	GCG	236;235;235	G;C;G,A	209;185;196,1	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1939	1941	GGC	225;224;225	G;G,C;C,T	210;208,1;209,1	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1948	1950	GGC	230;229;232	G,A;G;C,T	207,1;203;210,1	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	5116	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2468	206.8	1	SNP	p	L552S	0	.	.	1654	1656	CTG	1966	1968	CTG	221;222;219	C,G;T;G	178,5;167;175	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7084	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3161	223.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1663	1665	CCG	270;272;270	C;C;G	246;255;251	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2694	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1832	146.3	0	.	p	.	0	M83fs	FSHIFT	247	247	A	547	547	C	183	C	164	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	E48G	NONSYN	142	144	GAA	522	524	GGA	250;252;257	G;G;A	239;241;245	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	T87A	NONSYN	259	261	ACT	639	641	GCT	264;262;266	G,A;C;T,A	251,1;248;251,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	T89S	NONSYN	265	267	ACC	645	647	AGC	269;268;267	A;G;C,A	255;258;253,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	807	809	CAA	281;275;275	C;A;A	266;261;259	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	V151A	NONSYN	451	453	GTA	831	833	GCA	288;285;289	G;C,T,A;A	262;259,1,1;263	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	R187Q	NONSYN	559	561	CGA	939	941	CAA	283;287;288	C;A,G;A	270;270,1;272	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	N189S	NONSYN	565	567	AAC	945	947	AGC	294;291;294	A;G,A;C	276;268,2;275	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	0	.	p	.	0	Y212fs	FSHIFT	634	634	T	1014	1014	T	293	T	272	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	1	SNP	p	G120K	1	.	.	358	360	AAG	738	740	AAG	286;286;289	A;A;G,T	268;269;269,1	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	1	SNP	p	A121D	1	.	.	361	363	GAC	741	743	GAC	285;282;280	G;A,G;C	269;263,1;265	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	3518	porB1b	1041	1041	98.18	porB1b.l15.c17.ctg.1	1568	222.8	1	SNP	p	D121N	0	.	.	361	363	GAC	741	743	GAC	285;282;280	G;A,G;C	269;263,1;265	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	13058	rpoB	4179	4179	100.0	rpoB.l6.c4.ctg.1	4739	274.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1953	1955	CAT	268;266;272	C;A;T	255;254;258	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1450	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	990	144.9	1	SNP	p	V57M	1	.	.	169	171	ATG	463	465	ATG	325;319;319	A;T;G	304;301;299	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
